Tarsus Pharmaceuticals, Inc. (TARS) stock
TARSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/303% above fair value
$77.67+1.72 (+2.26%)
Close on Nov 19, 2026Market cap $3.41BP/E –Yield 0.00%
Tarsus Pharmaceuticals shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Tarsus Pharmaceuticals's shares outstanding was 43M at Jun 30, 2026. For fiscal 2025 it was 42M, up 11.1% from the year before. The highest annual figure on record is 42M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 42M | +11.1% |
| FY2024 | Dec 31, 2024 | 38M | +28.0% |
| FY2023 | Dec 31, 2023 | 29M | +19.3% |
| FY2022 | Dec 31, 2022 | 25M | +19.8% |
| FY2021 | Dec 31, 2021 | 21M | +231.1% |
| FY2020 | Dec 31, 2020 | 6M | +162.7% |
| FY2019 | Dec 31, 2019 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 43M | +2.4% |
| Q1 FY2026 | Mar 31, 2026 | 43M | +9.2% |
| Q4 FY2025 | Dec 31, 2025 | 43M | +10.9% |
| Q3 FY2025 | Sep 30, 2025 | 43M | +11.0% |
| Q2 FY2025 | Jun 30, 2025 | 42M | +12.0% |
| Q1 FY2025 | Mar 31, 2025 | 39M | +11.5% |
| Q4 FY2024 | Dec 31, 2024 | 39M | +15.7% |
| Q3 FY2024 | Sep 30, 2024 | 38M | +25.3% |
| Q2 FY2024 | Jun 30, 2024 | 38M | +41.0% |
| Q1 FY2024 | Mar 31, 2024 | 35M | +32.0% |
| Q4 FY2023 | Dec 31, 2023 | 33M | +24.8% |
| Q3 FY2023 | Sep 30, 2023 | 31M | +14.9% |
| Q2 FY2023 | Jun 30, 2023 | 27M | +10.2% |
| Q1 FY2023 | Mar 31, 2023 | 27M | +29.1% |
| Q4 FY2022 | Dec 31, 2022 | 27M | +65.7% |
| Q3 FY2022 | Sep 30, 2022 | 27M | +29.2% |
| Q2 FY2022 | Jun 30, 2022 | 24M | +10.8% |
| Q1 FY2022 | Mar 31, 2022 | 21M | -5.1% |
| Q4 FY2021 | Dec 31, 2021 | 16M | +490.5% |
| Q3 FY2021 | Sep 30, 2021 | 21M | +678.5% |
| Q2 FY2021 | Jun 30, 2021 | 22M | +728.8% |
| Q1 FY2021 | Mar 31, 2021 | 22M | +767.5% |
| Q3 FY2020 | Sep 30, 2020 | 3M | +10.5% |
| Q2 FY2020 | Jun 30, 2020 | 3M | – |
| Q1 FY2020 | Mar 31, 2020 | 3M | – |
| Q4 FY2019 | Dec 31, 2019 | 3M | – |
| Q3 FY2019 | Sep 30, 2019 | 2M | – |
See a number that looks wrong?